Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.820 -0.530 (-22.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock moved upwards by 43.27% to $2.45 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
Pot Stocks Down In June - Remain +29.6% YTD ↗
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each... 
Via Talk Markets
Topics Cannabis
News headline image
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o... 
Via Benzinga
News headline image
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗
Institutional analysts are taking a liking to the industry ... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers SCWorx (NASDAQ:WORX) shares rose ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021 ↗
Upgrades For Toll Brothers Inc (NYSE: 
Via Benzinga
News headline image
Privately Owned MagicMed Industries Inc. is Psyched to Join Forces with Public Pharma Co. Enveric ↗
MagicMed Industries Inc., a privately-held biotech company, recently announced its agreement to an acquisition by Enveric Biosciences (NASDAQ: ENVB). This joint venture may be the... 
Via Benzinga
News headline image
CEO Presenting on the Emerging Growth Conference on June 9. Register here
Niche Companies in Technology, Biotech, Precious Metals, and more in Attendance 
Via EIN Presswire
News headline image
EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences ↗
MagicMed Industries' focus is on creating new molecules based on psychedelics, said CEO Dr. Joseph Tucker — bu... 
Via Benzinga
News headline image
ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB
From Kahn Swick & Foti, LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA 
Via Benzinga
News headline image
Enveric Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Enveric Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ENVB
From Halper Sadeh LLP
Via Business Wire
News headline image
Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility ↗
The Nasdaq welcomed its third psychedelics company this week, with 
Via Benzinga
News headline image
52 Biggest Movers From Yesterday ↗
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 123.7% to $13.33 after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive... 
Via Benzinga
News headline image
Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries ↗
CBD-focused biotechnology company Enveric Biosciences (NASDAQ:... 
Via Benzinga
News headline image
30 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,... 
Via Benzinga
News headline image
48 Biggest Movers From Friday ↗
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago.... 
Via Benzinga
News headline image
21 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) rose 13.2% to $2.75 in pre-market trading after climbing over 11% on Thursday. The company recently reported a Q1 loss of $0.20... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
News headline image
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
News headline image
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week ↗
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Alterity Therapeutics (NASDAQ:ATHE) stock rose 23.16% to $1.54 during Wednesday's pre-market session. The company's market cap stands at $53.4 million.... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.